Kadmon Holdings, Inc.
Kadmon Holdings, Inc. (KDMN) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · KDMN · as of Jun 9, 2026
Key Statistics
Explore Kadmon Holdings, Inc. Data
kdmn stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 11 · Buy rate: 72.7%
Competitors & Peers
kdmn competitorsKDMN
AMAM
BLU
CALT
CINC
CTICStock Performance
Full HistoryAbout Kadmon Holdings, Inc.
Kadmon Holdings, Inc. Kadmon Holdings operates as a biopharmaceutical firm, focusing on the discovery, development, and commercialization of small molecule compounds and biologics, primarily to address inflammatory and fib…
what is kadmon holdings, inc. · kdmn stock overview · kadmon holdings, inc. company profile · who is kadmon holdings, inc. ceo · kdmn NYSE · kadmon holdings, inc. headquarters · kadmon holdings, inc. business segments
About Stock Overview & Key Data
Kadmon Holdings, Inc. (KDMN) is a Healthcare company in the Biotechnology industry, listed on NYSE since Jul 27, 2016. As of the latest trading session, KDMN stock price is $9.50, with a market capitalization of $0. The stock has returned +0.00% over the past 12 months and +0.00% year-to-date.
According to 11 Wall Street analysts, the consensus rating for Kadmon Holdings, Inc. stock is Buy, with an average 12-month price target of $—. In fiscal year 2020, Kadmon Holdings, Inc. reported revenue of $8.3M and net income of -$108.9M. For detailed data — including Kadmon Holdings, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Kadmon Holdings, Inc. (KDMN) stock price is $9.50. The stock is traded on NYSE under the ticker symbol KDMN. The 52-week range is $9.48 – $9.49.